Felbamate in the Treatment of Lennox‐Gastaut Syndrome

Epilepsia

Volumn 35, Issue , 1994, Pages S54-S57

  Jensen, Peder K ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Anticonvulsants ; Controlled clinical study; Drug toxicity ; Felbamate ; Lennox Gastaut syndrome

Indexed keywords

FELBAMATE;

CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; HUMAN; LENNOX GASTAUT SYNDROME; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SOMNOLENCE;

ADULT; ANTICONVULSANTS; CHILD; DRUGS, INVESTIGATIONAL; EPILEPSIES, PARTIAL; EPILEPSY; FOLLOW-UP STUDIES; HEMIPLEGIA; HUMANS; PLACEBOS; PROPYLENE GLYCOLS; SYNDROME;

EID: 0028129086     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1994.tb05969.x     Document Type: Article

References (6)

1. Felbamate: a double‐blind controlled trial in patients undergoing presurgical evaluation of partial seizures
2. Felbamate monotherapy for partial‐onset seizures: an active‐control trial
3. Felbamate for partial seizures: results of a controlled clinical trial
4. Felbamate monotherapy: controlled trial in patients with partial onset seizures
5. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox‐Gastaut syndrome)
6. Felbamate: a clinical trial for complex partial seizures